PMS16 Potential Cost Saving of Epoetin Alfa Compared to Autologous Blood Donation or to No-Blood-Conservation-Strategy Before Elective Hip or Knee Surgery Due to reduction in Allogeneic Blood Transfusions and Its Side Effects
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.402
https://www.valueinhealthjournal.com/article/S1098-3015(11)01964-4/fulltext
Title :
PMS16 Potential Cost Saving of Epoetin Alfa Compared to Autologous Blood Donation or to No-Blood-Conservation-Strategy Before Elective Hip or Knee Surgery Due to reduction in Allogeneic Blood Transfusions and Its Side Effects
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01964-4&doi=10.1016/j.jval.2011.08.402
First page :
A305
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
376